A Study to Determine the Safety and Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of the Knee
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Moon Jong Noh, PhD
Kolon TissueGene, Inc.
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
44 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Bradly Goodman
Birmingham, Alabama, United States
- Jeffrey Davis
Birmingham, Alabama, United States
- Saima Chohan
Phoenix, Arizona, United States
- Nebojsa Skrepnik
Tucson, Arizona, United States
- Diraj Karnani
Apple Valley, California, United States
- Dan la
Covina, California, United States
- Scott Hacker
La Mesa, California, United States
- Eric Grigsby
Napa, California, United States
- Arthur Mabaquiao
San Diego, California, United States
- Timothy Davis
Santa Monica, California, United States
- Tien-I Su
Whittier, California, United States
- Mehul Desai
Washington D.C., District of Columbia, United States
- David Billmeier
Daytona Beach, Florida, United States
- Aurelio Torres-Consuegra
Miami, Florida, United States
- Edgar Gonzalez
Miami, Florida, United States
- Mercedes Ponce de Leon
Miami, Florida, United States
- Cathy Barnes
New Port Richey, Florida, United States
- Howard Chipman
Oldsmar, Florida, United States
- Richard Linn
Sunrise, Florida, United States
- Anand Patel
Winter Park, Florida, United States
- Sandeep Vaid
Newnan, Georgia, United States
- Dennis Levinson
Chicago, Illinois, United States
- Manish Jain
Chicago, Illinois, United States
- Hythem Shadid
Oak Brook, Illinois, United States
- Adil Fatakia
Marrero, Louisiana, United States
- James Nace
Baltimore, Maryland, United States
- Melvin Churchill
Lincoln, Nebraska, United States
- Jason Oh
New York, New York, United States
- Brett Gilbert
Durham, North Carolina, United States
- Jeremy Hoff
Wilmington, North Carolina, United States
- Yogesh Mittal
Tulsa, Oklahoma, United States
- Alan Kivitz
Duncansville, Pennsylvania, United States
- Edward Tavel
Columbia, South Carolina, United States
- Eric Loudermilk
Greenville, South Carolina, United States
- Harvey Bowles
Nashville, Tennessee, United States
- Daneshvari Solanki
Bellaire, Texas, United States
- Amr Morsy
Dallas, Texas, United States
- Haresh Boghara
DeSoto, Texas, United States
- Aldo Maspons
El Paso, Texas, United States
- Subodh Bhuchar
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Oct 2018
- Primary completion
- 10 Jul 2024
- Completion
- 10 Jul 2026
- Last update posted
- 30 Dec 2025
- Registered enrollment
- 535
- Registry id
- NCT03203330
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.